Related Experiment Video
Updated: Aug 9, 2026
12:18
Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)
Published on: February 9, 2011
Juvenile cellulitis in an 8-month-old dog
R J Bassett1, G G Burton, D C Robson
1Melbourne Veterinary Referral Centre, Glen Waverley, Victoria 3150.
Australian Veterinary Journal
|June 17, 2005
Summary
Canine juvenile cellulitis, a rare skin condition, can affect older puppies. This case report details successful treatment with glucocorticoids in an 8-month-old dog, highlighting a novel age presentation for this disease.
Area of Science:
- Veterinary Dermatology
- Canine Pathology
Background:
- Canine juvenile cellulitis (also known as puppy strangles) is an uncommon immune-mediated skin disease typically affecting young dogs.
- Early diagnosis and treatment are crucial for managing this condition.
Observation:
- An 8-month-old crossbred dog presented with a four-week history of a painful, swollen face unresponsive to antibiotic therapy.
- Clinical signs included facial swelling and pain, suggestive of an inflammatory or infectious process.
Findings:
- Diagnosis was confirmed through clinical presentation, cytology, and histopathology, ruling out canine distemper virus.
- The dog showed a complete resolution of clinical signs following treatment with glucocorticoids.
Implications:
- This case expands the known age range for canine juvenile cellulitis, with this being the first report in an 8-month-old dog.
- Glucocorticoid therapy is effective in managing canine juvenile cellulitis, even in atypical age presentations.
- Highlights the importance of considering immune-mediated conditions in young dogs with persistent facial swelling.
Related Concept Videos
01:26Tonsillitis II: Management
This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
01:28Pneumonia IV: Management
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:27Acute Pyelonephritis I: Introduction
Pyelonephritis is a bacterial infection that primarily affects the renal parenchyma and collecting system, including the renal pelvis, tubules, and interstitial tissue of one or both kidneys. It can be classified as either acute—a sudden, severe infection—or chronic, which refers to long-term or recurrent kidney infections.The primary cause of acute pyelonephritis (APN) is bacterial infection, with Escherichia coli accounting for approximately 70-80% of cases. Other bacteria, such as Proteus,...
01:28Acute Pyelonephritis II: Diagnostic Studies and Management
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
01:29Staphylococcal Skin Infections
Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
01:24Bacterial Meningitis
Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...